Position in AMGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$48,458,174
+$35,522 QoQ
Shares Held
133,818
-2.8% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#225
of 3,139 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $673,665,379 across 15 Drug Manufacturers - General names. AMGN ranks #5 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
222,559 | $266,943,963 | |
| 2 | JNJ |
Johnson & Johnson
|
466,851 | $118,566,148 | |
| 3 | ABBV |
AbbVie Inc.
|
350,912 | $88,303,495 | |
| 4 | MRK |
Merck & Co., Inc.
|
473,483 | $60,842,565 | |
| 5 | AMGN |
Amgen Inc
This page
|
133,818 | $48,458,174 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
238,168 | $30,090,145 | |
| 7 | PFE |
Pfizer Inc
|
1,108,420 | $26,690,753 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
444,025 | $25,584,720 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,458,174 | 133,818 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $48,422,652 | 137,623 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $41,022,744 | 125,333 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $33,586,033 | 119,015 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $33,523,627 | 120,066 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $36,739,845 | 117,926 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $30,328,591 | 116,362 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $38,248,904 | 118,708 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $37,449,632 | 119,858 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $32,606,670 | 114,683 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $32,168,953 | 111,690 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $29,016,404 | 107,964 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $23,758,804 | 107,012 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $27,900,125 | 115,409 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $29,660,460 | 112,932 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $23,214,847 | 102,994 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $23,062,650 | 94,791 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $24,536,024 | 101,464 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $22,796,660 | 101,332 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $19,806,858 | 93,143 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $23,574,037 | 96,714 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $26,732,892 | 107,443 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $24,757,095 | 107,677 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $27,400,989 | 107,810 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $26,565,147 | 112,631 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||